ReACp53 could inhibit p53 amyloid formation and rescue p53 function in cancer cell lines.
CAT No: R1654
ReACp53 is a synthetic peptide designed to modulate the structural conformation of the tumor suppressor protein p53, particularly targeting its aggregation-prone mutant forms. As a rationally engineered peptide inhibitor, ReACp53 is distinguished by its ability to interact with the aggregation domain of p53, thereby preventing or reversing aberrant self-association that can compromise p53's native function. Its unique mechanism of action has rendered it a valuable molecular tool for investigating the structural biology of p53, elucidating the consequences of protein misfolding, and exploring strategies to restore wild-type p53 activity in various cellular contexts. Owing to these attributes, ReACp53 has garnered significant interest within the fields of cancer biology, protein aggregation research, and peptide-based modulation of protein-protein interactions.
Protein aggregation studies: In the context of protein misfolding research, ReACp53 serves as a highly specific probe for dissecting the mechanisms underlying p53 aggregation. Its ability to selectively bind the aggregation-prone motif within mutant p53 enables researchers to examine the kinetics, thermodynamics, and structural determinants of p53 oligomerization in vitro and in cell-based systems. By providing a means to modulate aggregation, the peptide allows scientists to distinguish between the effects of loss of function and gain of toxic function associated with p53 misfolding, thereby advancing our understanding of protein homeostasis in oncogenic settings.
Functional rescue assays: The peptide is widely utilized in functional assays aimed at restoring wild-type-like activity to mutant p53 proteins. By disrupting or preventing aggregation, ReACp53 facilitates the refolding or stabilization of p53's functional conformation, which can be quantitatively assessed through reporter gene assays, transcriptional activity measurements, and downstream target gene expression analyses. These studies yield critical insights into the feasibility of peptide-mediated rescue of tumor suppressor function and inform the development of novel strategies for reactivating dysfunctional proteins in disease models.
Peptide-protein interaction analysis: ReACp53 provides a robust platform for investigating the molecular basis of peptide-mediated modulation of protein-protein interactions. Its well-characterized sequence and binding specificity enable detailed biophysical and structural studies, including surface plasmon resonance, isothermal titration calorimetry, and nuclear magnetic resonance spectroscopy. Such analyses help elucidate the binding interfaces, affinities, and conformational changes associated with peptide binding, contributing to the broader field of rational peptide design and protein engineering.
Cancer cell biology research: Experimental systems employing ReACp53 permit the study of mutant p53's role in cellular transformation, proliferation, and stress response pathways. By manipulating p53 aggregation status, researchers can dissect the downstream effects on cell cycle regulation, apoptosis, and DNA damage response in both two-dimensional cultures and three-dimensional organoid models. These investigations are essential for clarifying the pathological consequences of p53 dysfunction and for identifying molecular checkpoints susceptible to therapeutic intervention in oncology research.
Peptide-based screening and discovery: The use of ReACp53 as a reference or control compound in high-throughput screening campaigns supports the identification and validation of new aggregation inhibitors or p53 modulators. Its defined mechanism of action and reproducible bioactivity make it an ideal benchmark for comparative evaluation of novel peptides, small molecules, or biologics. Such screening efforts facilitate the expansion of chemical and biological toolkits for modulating protein aggregation, thereby accelerating discovery in both basic and translational research settings.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More